陕西盘龙药业集团股份有限公司关于2026年第一次临时股东会决议公告

Meeting Details - The first temporary shareholders' meeting of 2026 was held on January 16, 2026, at 14:00 [1] - The meeting combined on-site voting and online voting, with specific time slots for each [2] - The meeting was convened by the board of directors and presided over by Chairman Mr. Xie Xiaolin [3][4] Attendance - A total of 245 shareholders attended the meeting, representing 43,820,617 shares, which is 41.3763% of the total voting shares [5] - Among them, 7 shareholders attended in person, representing 39,536,232 shares (37.3309%), while 238 participated via online voting, representing 4,284,385 shares (4.0454%) [5] - Small and medium shareholders accounted for 5,359,385 shares (5.0604%) of the total voting shares [6] Resolutions Passed - The proposal to conclude fundraising projects and permanently supplement working capital with surplus funds was approved, with 43,776,623 shares (99.8996%) in favor [8] - The proposal to elect additional members to the fifth board of directors was also approved, with 43,774,186 shares (99.8940%) in favor [11] Legal Opinion - The legal opinion provided by Beijing Ruqiang Law Firm confirmed that the meeting's procedures, attendance qualifications, and voting processes complied with relevant laws and regulations, deeming the resolutions legal and valid [14]